The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

AGC Bi­o­log­ics, Bio­Con­nec­tion forge part­ner­ship to be an al­ter­na­tive to WuXi

Last year
China

Evotec ends gene ther­a­py busi­ness, shuts down fa­cil­i­ty in Aus­tria

Last year
Pharma
Cell/Gene Tx

As­traZeneca ear­marks $1.5B for end-to-end ADC fac­to­ry in Sin­ga­pore

Last year

WuXi Bi­o­log­ics paus­es Mass­a­chu­setts build; No­vo Hold­ings nabs ma­jor­i­ty stake in phar­ma tools firm  

Last year

Aim­ing to de­cen­tral­ize CAR-T man­u­fac­tur­ing, Gala­pa­gos part­ners with largest US blood sup­ply net­work

Last year
Cell/Gene Tx

Mer­ck KGaA stays pos­i­tive on CD­MO arm’s fu­ture de­spite first-quar­ter slump

Last year

WuXi AppTec trims 's­mall per­cent­age' of work­ers at US site as mar­ket shifts

Last year
People

New­Vale un­veils $167M fund to back phar­ma ser­vice providers and 'old ideas that are work­ing'

Last year
Financing
Outsourcing

Up­dat­ed: France draws €2B+ re­search, man­u­fac­tur­ing in­vest­ment from Sanofi, Pfiz­er, As­traZeneca, GSK

Last year
Financing

AGC Bi­o­log­ics to cut close to 4% of staffers 'to ad­just busi­ness pri­or­i­ties'

Last year
People

Charles Riv­er touts first-quar­ter man­u­fac­tur­ing rev­enue, says Chi­na bill is ‘net pos­i­tive’

Last year
China

Nu­cle­us Ra­dio­Phar­ma makes Art­bio’s ra­dio­phar­ma as­sets; Mi­naris man­u­fac­tures blue­bird’s Lyf­ge­nia 

Last year

Te­va to close ad­di­tion­al man­u­fac­tur­ing sites as it en­ters next phase of 'piv­ot to growth'

Last year
Pharma

BeiGene ear­marks $74M to build fourth fa­cil­i­ty in Chi­na

Last year
China

FTC wants more in­for­ma­tion on No­vo-Catal­ent deal in an­titrust re­view

Last year
Deals

Bi­par­ti­san draft bill would pay hos­pi­tals more to com­bat drug short­ages

Last year
Pharma

Emer­gent to shut fa­cil­i­ties and lay off work­ers as part of new CEO’s roadmap

Last year

Avid Bio field­ing client in­quiries due to Chi­na bill; Ox­ford Bio wants to dou­ble its rev­enues

Last year

Up­dat­ed: Lil­ly boosts sales guid­ance by $2B, but GLP-1 sup­ply con­straints still a fo­cus

Last year
Pharma

WuXi wants to re­gain client con­fi­dence amid claims of IP trans­fer to Chi­nese au­thor­i­ties 

Last year
China

Mer­ck KGaA to ex­pand Ger­man head­quar­ters with €300M+ re­search cen­ter 

Last year
R&D

Ther­mo Fish­er ex­pects last­ing ben­e­fits to bill tar­get­ing Chi­nese ser­vice providers

Last year
China

Roche un­ruf­fled by Chi­na bill as it looks to grow roots in the re­gion

Last year
China

Drug and biotech com­pa­nies join lob­by­ing push on Chi­na bill as scruti­ny of WuXi con­tin­ues

Last year
China
Pharma
First page Previous page 12131415161718 Next page Last page
A service from the Financial Times